What changed
FACT (Federal Register, 2026-06-04): a new federal rule on Independent Dispute Resolution operations standardizes machine-readable denial/payment reason codes (CARCs/RARCs) in out-of-network remittances. FACT (signal sources): sub-35M-parameter multilingual OCR (PP-OCRv6) makes cheap self-hosted EOB/document extraction practical, and GPT-5.6 lowers per-task reasoning cost. Together, the inputs to IDR-eligibility triage become machine-parseable at near-zero marginal cost for the first time.
Why now
The rule creates a dated compliance transition: payers must emit standardized codes, so provider-side parsing that was previously bespoke per-payer becomes a standard schema problem. Early movers can build against the standard before incumbent RCM suites fully retool. HYPOTHESIS: a 6-18 month window before denial-management incumbents ship equivalent parsing.
Converging signals
(1) Regulation: Federal IDR Operations rule mandating machine-readable CARC/RARC in OON remittances. (2) Capability: PP-OCRv6 — accurate OCR on minimal CPU, no cloud OCR API cost or PHI leaving the box. (3) Capability: GPT-5.6-class cost-performance makes per-claim eligibility reasoning economical. All three cited from provided sources.
Customer pain
HYPOTHESIS (no demand_evidence provided in this input): OON-heavy provider groups (ER staffing, anesthesia, radiology, air ambulance) and their billing companies leave money on the table because IDR has short, hard deadlines (open-negotiation and initiation windows) and eligibility rules that clerks misjudge; missed windows are unrecoverable revenue. This is consistent with the existence of the IDR process itself but is NOT proven by evidence in this input.
Who pays
Small/mid RCM billing companies and independent specialty groups that handle their own OON claims — reachable buyers with direct P&L exposure to missed IDR windows. NOT hospital enterprise procurement.
Solved today
HYPOTHESIS: manual review of 835s/EOBs by billing staff; contingency-fee IDR services (e.g., HaloMD, Aspirion) that take a large cut of awards; big RCM suites (Waystar, Experian Health) with generic denial-management modules not yet tuned to the new machine-readable OON codes.
Why current solutions are bad
Contingency vendors take 15-35% of recoveries and cherry-pick high-value disputes; manual triage misses deadlines on the long tail of smaller claims; incumbent suites are enterprise-priced and slow to adapt to the new code standard. HYPOTHESIS throughout — no spend evidence was supplied.
Proposed product
Upload-first web tool (no EHR integration for MVP): drop in 835 remittance files / EOB PDFs → local OCR (PP-OCRv6) + CARC/RARC parser → deterministic eligibility rules engine with LLM assist only for ambiguous disclosure text → output: IDR-eligible? which deadline clock is running? pre-filled open-negotiation notice and federal IDR portal initiation packet. Charge per processed dispute.
MVP version
CARC/RARC parser for the new standardized codes + deadline calculator + eligibility checklist + generated negotiation-notice PDF. Skip PHI-heavy features initially by processing redacted/minimum-necessary fields; sign BAAs once first paying customer requires it.
30-day build
Validate demand (this input has ZERO demand evidence — that is the gating risk, not the build): 15 outreach conversations with OON-heavy billing companies; scrape r/CodingandBilling, RCM job postings for 'IDR'/'No Surprises Act' roles to prove existing spend. In parallel, build the code parser against the published rule schema.
60-day build
Working triage pipeline on real (test/redacted) 835s; 3 design partners running side-by-side against their manual process; measure missed-deadline catch rate as the demo metric.
90-day revenue plan
Convert design partners at per-dispute pricing ($15-40/dispute) or $300-600/mo per billing-team seat bundle. Founder profile supports a 3-6 month ramp; first revenue realistically day 120-180 given healthcare buyer caution.
Distribution path
Direct demonstrated-value outreach: run a batch of a prospect's redacted remittances through the tool and hand back a 'missed IDR dollars' report. Niche channels: HBMA/AAPC communities, medical-billing Facebook/Reddit groups, RCM newsletters. No ad spend needed.
Pricing hypothesis
Per-dispute transaction fee ($15-40) mirroring the founder's proven per-upload ELDT model, plus optional monthly minimum. Undercuts 15-35% contingency vendors by an order of magnitude on high-value claims.
Technical difficulty
Moderate. X12 835 parsing is well-trodden; the new standardized codes reduce (not increase) parsing difficulty; OCR and reasoning components are commodity per the cited signals. The hard part is encoding IDR eligibility/deadline rules correctly — a systems-thinking problem, which suits the founder.
Legal / regulatory risk
Real but manageable: PHI ⇒ HIPAA obligations and BAAs once handling live claims (on-device OCR is a genuine mitigant — data never leaves customer-controlled infra). Must avoid unauthorized-practice-of-law framing: the tool prepares packets and flags eligibility, the biller decides. Not a medical device.
Platform dependency
Low. Depends on the federal IDR portal remaining the filing venue and the rule surviving as written; no app-store or social-platform exposure. Rule changes are a tail risk (the IDR regime has been litigated repeatedly — HYPOTHESIS from general knowledge, not cited sources).
Founder fit
Mixed-to-good. The shape matches his proven ELDT edge: a federal rule standardizes data, a party must file into a federal portal under deadlines, monetize per filing. BUT two deviations from the ELDT template: the filer is not FORCED (IDR initiation is optional revenue recovery, not a compliance mandate on the buyer), and healthcare RCM is outside his domain credibility, unlike transport/industrial. Score 6, not 8-9 — the accumulated lesson about government-portal mandates (conf 0.80) applies only partially because the forced-buyer element is on payers, not the paying customer.
Breakout potential
Good if the wedge lands: denial triage expands naturally into full denial-management-lite for small billing companies, state surprise-billing arbitration regimes, and payer-behavior analytics data products.
Final recommendation
CONDITIONAL PURSUE — do not build the full product yet. The convergence is real and the mechanics suit the founder, but demand is unproven IN THIS INPUT and the space has entrenched alternatives. Spend 2-3 weeks on demand validation (interviews + evidence mining); build only the parser/deadline demo as the sales artifact. If 3+ billing companies confirm they miss IDR windows and reject contingency pricing, proceed; otherwise archive.
Next action
Mine demand evidence: search RCM job boards for 'IDR analyst'/'No Surprises Act' roles and billing-community complaints about missed IDR deadlines; simultaneously read the cited Federal Register rule in full and extract the exact CARC/RARC schema and compliance dates.